D.A. Davidson & CO. Has $641,000 Holdings in MiMedx Group, Inc. (MDXG)

D.A. Davidson & CO. grew its position in MiMedx Group, Inc. (NASDAQ:MDXG) by 282.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 91,900 shares of the medical equipment provider’s stock after purchasing an additional 67,900 shares during the quarter. D.A. Davidson & CO.’s holdings in MiMedx Group were worth $641,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Dimensional Fund Advisors LP raised its holdings in shares of MiMedx Group by 15.5% during the third quarter. Dimensional Fund Advisors LP now owns 48,930 shares of the medical equipment provider’s stock worth $581,000 after acquiring an additional 6,573 shares during the period. California Public Employees Retirement System raised its holdings in shares of MiMedx Group by 25.0% during the third quarter. California Public Employees Retirement System now owns 81,347 shares of the medical equipment provider’s stock worth $966,000 after acquiring an additional 16,247 shares during the period. Bowling Portfolio Management LLC raised its holdings in shares of MiMedx Group by 28.1% during the fourth quarter. Bowling Portfolio Management LLC now owns 58,492 shares of the medical equipment provider’s stock worth $738,000 after acquiring an additional 12,829 shares during the period. Strs Ohio raised its holdings in shares of MiMedx Group by 275.3% during the fourth quarter. Strs Ohio now owns 278,100 shares of the medical equipment provider’s stock worth $3,506,000 after acquiring an additional 204,000 shares during the period. Finally, Ferguson Wellman Capital Management Inc. acquired a new stake in shares of MiMedx Group during the fourth quarter worth $460,000. Institutional investors own 79.28% of the company’s stock.

Shares of MDXG stock opened at $7.32 on Friday. MiMedx Group, Inc. has a 1 year low of $6.94 and a 1 year high of $7.05. The firm has a market capitalization of $777.24 million, a price-to-earnings ratio of 33.33, a price-to-earnings-growth ratio of 0.91 and a beta of 1.54.

A number of equities research analysts recently commented on MDXG shares. Lake Street Capital lowered shares of MiMedx Group from a “buy” rating to a “hold” rating and set a $9.00 price objective on the stock. in a report on Friday, February 23rd. ValuEngine lowered shares of MiMedx Group from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 2nd. BidaskClub upgraded shares of MiMedx Group from a “sell” rating to a “hold” rating in a report on Wednesday, March 7th. Needham & Company LLC lowered shares of MiMedx Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 20th. Finally, Craig Hallum reiterated a “buy” rating on shares of MiMedx Group in a research note on Tuesday, February 27th. Four investment analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $14.75.

About MiMedx Group

MiMedx Group, Inc, a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts.

Want to see what other hedge funds are holding MDXG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MiMedx Group, Inc. (NASDAQ:MDXG).

Institutional Ownership by Quarter for MiMedx Group (NASDAQ:MDXG)

Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply